ProCE Banner Activity

Optimizing Use of BTK Inhibitors in CLL/SLL and MCL for Managed Care Professionals

Slideset

Download these slides from a live webinar to learn more about the latest data supporting the efficacy and safety of BTK inhibitor–based therapeutic approaches for patients with CLL/SLL or MCL, including strategies to promote equitable, cost-effective, and evidence-based care for patients with these diseases.

Released: January 11, 2024

Share

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly